<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-152696</identifier>
<setSpec>1137-6627</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cholestasic toxic hepatitis due to clopidogrel in a patient with multiple conditions</dc:title>
<dc:description xml:lang="en">Clopidogrel is a thienopyridine-class antiplatelet drug commonly used in ischemic heart disease, cerebrovascular disease and peripheral artery disease. Liver toxicity due to this drug is very infrequent. We found 16 cases in the literature, and in only two of them liver biopsy was carried out. We report the case of a 78 year old patient with multiple conditions affected by severe toxic cholestatic hepatitis due to clopidogrel and the results of the liver biopsy performed. Hepatitis was resolved after discontinuing the drug. Based on the characteristics of this case and other previously published cases, we review the characteristics of toxic hepatitis due to clopidogrel and its diagnosis and treatment (AU)</dc:description>
<dc:creator>Méndez-López, I</dc:creator>
<dc:creator>Etxeberria-Lekuona, D</dc:creator>
<dc:creator>Jarne, V</dc:creator>
<dc:creator>Oteiza, J</dc:creator>
<dc:creator>Arteaga, M</dc:creator>
<dc:creator>Mercado, MR</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El clopidogrel es un fármaco antiagregante de la familia de la tienopiridinas muy utilizado en pacientes con cardiopatía isquémica, ictus y arteriopatía periférica. La toxicidad hepática por este fármaco es muy infrecuente. En la bibliografía únicamente se han descrito 16 casos, y solo en dos de ellos se practicó una biopsia hepática. Se presenta el caso de un paciente de 78 años pluripatológico que presentó una hepatitis tóxica colestásica severa por este fármaco y los hallazgos de la biopsia hepática que se le realizó. El cuadro se resolvió tras la retirada del fármaco. En base a los hallazgos de nuestro caso y los de los casos previamente publicados se revisan las características de la hepatitis tóxica por clopidogrel y su manejo diagnóstico y terapéutico (AU)</dc:description>
<dc:source>An Sist Sanit Navar;39(1): 143-148, ene.-abr. 2016. graf, ilus</dc:source>
<dc:identifier>ibc-152696</dc:identifier>
<dc:title xml:lang="es">Hepatitis tóxica colestástica por clopidogrel en un paciente pluripatológico</dc:title>
<dc:subject>^d28563^s22057</dc:subject>
<dc:subject>^d4421^s22012</dc:subject>
<dc:subject>^d8985^s22073</dc:subject>
<dc:subject>^d8272^s22009</dc:subject>
<dc:subject>^d22965^s22020</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d5337^s22012</dc:subject>
<dc:subject>^d5337^s22036</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d8272^s22063</dc:subject>
<dc:subject>^d6657^s22012</dc:subject>
<dc:subject>^d8272^s22053</dc:subject>
<dc:subject>^d1731</dc:subject>
<dc:subject>^d2829^s22012</dc:subject>
<dc:subject>^d2829^s22036</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201604</dc:date>
</metadata>
</record>
</ibecs-document>
